I. Kiyoto

The potent anti-tumor-promoting agent isoliquiritigenin.

S. Yamamoto, H. Jiang, R. Kato, 1991, Carcinogenesis.

Staurosporine, a potent protein kinase C inhibitor, fails to inhibit 12-O-tetradecanoylphorbol-13-acetate-caused ornithine decarboxylase induction in isolated mouse epidermal cells.

S. Yamamoto, R. Kato, E. Aizu, 1987, Biochemical and biophysical research communications.

Comparison of some biochemical properties of epidermis in tumor promotion-susceptible and -resistant strains of mice.

S. Yamamoto, T. Nakaki, R. Kato, 1988, Japanese journal of pharmacology.

The induction of ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate in isolated epidermal cells is inhibited by lipoxygenase inhibitors but not by cyclooxygenase inhibitors.

S. Yamamoto, R. Kato, N. Sasakawa, 1987, European journal of pharmacology.

Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.

S. Yamamoto, Y. Hosoda, R. Kato, 1989, Carcinogenesis.

Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis.

S. Yamamoto, R. Kato, T. Nakadate, 1988, Carcinogenesis.